Evidence map›Paper›PMID 22546909›Full record

ArticleVirulence2012

Salicylate increases the expression of marA and reduces in vitro biofilm formation in uropathogenic Escherichia coli by decreasing type 1 fimbriae expression.

Jordi Vila, Sara M Soto

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Antimicrobial Effects of Antipyretics.Antimicrobial agents and chemotherapy · 2017
    Review
  13. Article
  14. Review
  15. Review
  16. MarA, SoxS and Rob ofInternational journal of biotechnology for wellness industries · 2013
    Article
  17. Article
  18. Inactivation of MarR gene homologs increases susceptibility to antimicrobials in Bacteroides fragilis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jordi VilaBarcelona Centre for International Health Research, CRESIB, Hospital Clinic-University of Barcelona, Barcelona, Spain.
Sara M Soto
Universitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli is one of the most frequent bacteria implicated in biofilm formation, which is a dynamic process whose first step consists in bacteria adhesion to surfaces through type 1 fimbriae. Salicylate induces a number of morphological and physiological alterations in bacteria including the activation of the transcriptional regulator MarA. In this report the effects of salicylate on biofilm formation and their relationship with MarA were studied. An inverse relationship was observed between in vitro biofilm formation and salicylate concentration added to the culture medium. Salicylate increases the expression of marA and decreases the expression of fimA and fimB genes in the wild-type strain. In addition, the fimA and fimB expression was decreased in a MarR mutant in which marA was also overexpressed. In conclusion, the expression of type 1 fimbriae in presence of salicylate may be regulated by the level of marA expression through fimB regulator, albeit through neither the ompX nor the tolC genes.

Indexed as

Anti-Bacterial AgentsBiofilmsDNA-Binding ProteinsEscherichia coli ProteinsFimbriae, BacterialFimbriae ProteinsGene Expression ProfilingIntegrasesSalicylatesTranscriptional ActivationUropathogenic Escherichia coliAnti-Bacterial AgentsDNA-Binding ProteinsEscherichia coli ProteinsfimB protein, E coliFimbriae ProteinsfimbrillinIntegrasesMarA protein, E coliSalicylates

Identifiers

PMID22546909
PMCPMC3442840
OpenAlexW2067645344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.